Human Biomonitoring in EU- Funded Research: an update

Similar documents
MESSAGE FROM DG RESEARCH

COMMISSION OF THE EUROPEAN COMMUNITIES

Effectiveness Evaluation of Stockholm Convention

Health Impact Quantification : DG Research and Innovation perspectives

(Preface and Executive Summary only. The full report will be posted on STAP s website shortly at

COMMISSION OF THE EUROPEAN COMMUNITIES

Council of the European Union Brussels, 6 December 2016 (OR. en)

Prioritization of biomarkers in the French human biomonitoring programme

JOINING FORCES ACROSS EUROPE FOR PREVENTION AND PROMOTION IN MENTAL HEALTH. Barcelona, Spain. Mental Health Promotion and DG Employment

Persistent Organic Pollutants National Implementation Plan of Georgia

Advanced methodology for the prioritisation of contaminants and contaminant mixtures in the aquatic environment (SOLUTIONS WP S2)

Community Research on Climate Change and Health: From FP5 to FP7

ETUC RESOLUTION ON NANOTECHNOLOGIES AND NANOMATERIALS

Community-funded research on air pollution and health

Toxicology for the future research, development and education for chemical safety Welcome!

Implementation of REACH and CLP: Overview, Status and post 2018 possible actions

CHEMICALS LEGAL BASIS ACHIEVEMENTS

HBM4EU Launch event. Key features from the HBM4EU Data management and infrastructure for HBM4EU

HESI VALUE: Translational Safety Biomarker Assessment of Neurotoxicity Proposal

Questions and Answers on the Thematic Strategy on the Urban Environment

Health and Safety at Work

State-based Biomonitoring Programs and NHANES Exposure Data

REGULATORY ACTIONS UNDER REACH & CLP FEEDBACK FROM ECHA S RAC

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents

Council of the European Union Brussels, 16 January 2017 (OR. en)

5965/18 OM/vc 1 DGG 1B

Justification Document for the Selection of a CoRAP Substance - Update -

Research & Innovation in food, health and ageing

Re: Looking Forward: Recommendations concerning the workplan for medium priority chemicals under the Chemicals Management Plan

EU Research and Innovation in support to chemical safety

FSC STANDARD. Indicators and thresholds for the identification of highly hazardous pesticides (HHP) Forest Stewardship Council FSC-STD V1-0 EN

The Federal Institute of Risk Assessment at a glance dates, facts and background

Provisional report on the implementation progress of the Community Strategy

Threshold limit values for chemical substances - the experience of SCOEL -

WORK PLAN BY THE STOCKHOLM CONVENTION REGIONAL CENTRES

Health Care Waste Management - To Reduce the Burden of Disease, Health- Care Waste Needs Sound Management, Including Alternatives to Incineration

Long-Range Research Initiative Global Research Strategy. 21st Century Approaches to Risk Sciences

Human Exposure Assessment and Risk Assessment (part 1)

Synergies and Trade-offs of Nature Conservation and Health Implications for sustainable (urban) Health Planning from a German perspective

Towards a Pollution Free Planet Preparation of the background document

National human biomonitoring programme in France: selection of substances and prioritization of biomarkers

Rainer Friedrich. 37th TFIAM meeting. University of Stuttgart

Revision of the Energy Efficiency Directive. Position Paper. Brussels, 05 April 2017

Environmental Impact Assessment (EIA) Owen Struthers Development Management Branch Welsh Government

Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL

EUROPEAN UNION. Brussels, 27 February 2014 (OR. en) 2012/0190 (COD) PE-CONS 120/13 ENV 1159 ENT 332 CODEC 2811

JOINT FAO/WHO FOOD STANDARDS PROGRAMME CODEX COMMITTEE ON PESTICIDE RESIDUES 50 th Session Haikou, P.R. China, 9-14 April 2018

Biologically effective dose Early biological effect Susceptibility Biomarker of effect

Official Journal of the European Union L 314/9 DECISIONS COUNCIL

8201/10 KZV/mko 1 DG I - 1A

EVALUATION AND FITNESS CHECK (FC) ROADMAP. A. Purpose

REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL

Action Plan for Biodiversity Research in Europe European Platform for Biodiversity Research Strategy Aims Background

Horizon 2020 Societal Challenges

Endocrine discuptors under REACH

EN 1 EN 1. INTRODUCTION

(Text with EEA relevance)

Current activities of the European Commission in the area of pesticide residues

COMMISSION DIRECTIVE 2010/60/EU

Official Journal of the European Union

International recognition

Environmental justice and interpretation of human biomonitoring results

REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL

Chemical Risk Services

European Human Biomonitoring Initiative (HBM4EU)

Chemical Risk Services

EFSA s Approach for the Safety Evaluation of Nanotechnology Products in the Food and Feed Area

Committee on the Environment, Public Health and Food Safety. of the Committee on the Environment, Public Health and Food Safety

CANADA. Highlight of Developments since the 3 rd Meeting of the WPMN. meeting of the OECD Working Party on

HPD Open Standard Supplemental List Update Policy July 2, 2018

Interface between REACH and CAD:

Review of the List of restricted substances under RoHS II

Werknorm BN e Material Compliance Blatt 1 von 7

Council Directive 98/59/EC of 20 July 1998 on the approximation of the laws of the Member States relating to collective redundancies

Import tolerances in the European Union Can Import Tolerances be set for active substances impacted by the EU hazard-based criteria?

DRAFT OPINION. EN United in diversity EN. European Parliament 2017/0224(COD) of the Committee on Industry, Research and Energy

The most important items in the new EU pesticide Regulation

COMMISSION RECOMMENDATION. of (Text with EEA relevance)

EUROCHAMBRES and UEAPME s amendment proposals on the revision of the Waste Framework Directive

COUNCIL DIRECTIVE 98/59/EC of 20 July 1998 on the approximation of the laws of the Member States relating to collective redundancies

Screening Serbia Explanatory meeting. Computerization March 2014

REACH: how to deal with 30,000 chemicals

CHARTER OF THE REGIONS AND LOCAL AUTHORITIES OF EUROPE ON THE SUBJECT OF COEXISTENCE OF GENETICALLY MODIFIED CROPS WITH TRADITIONAL AND ORGANIC

United Nations Environment Programme

Procedure For The Management Of Polychlorinated Biphenyls

Per Bergman Head of the GMO Unit. GMO conference Brussels, September 2009

Title 38: WATERS AND NAVIGATION

Infrastructures and procedures for a sustainable HBM applied in the U.S. National Health and Nutrition Examination Survey (NHANES)

Workshop Assessment of Persistent, Bioaccumulative and Toxic (PBT) substances in different EU legislations

Action against litter and littering an integral part of the Commission's Circular Economy Action Plan

Regulatory framework for seed treatments in the EU

Official Journal of the European Union

REACH REGULATION: the new management of chemicals in Europe and operational tools. R egistration. E valuation. A Ch. uthorisation.

RSPG opinion on the process for EU assistance in bilateral negotiations with third countries and between EU countries

EUROPEAN UNION. Brussels, 22 January 2014 (OR. en) 2012/0191 (COD) PE-CONS 106/13 ENV 965 ENT 290 CODEC 2362

The ecosystem service approach to make protection goals operational. Lorraine Maltby

GMO Asynchronous and Asymmetric Approvals: Bringing lasting solutions to identified problems CEN/ENEA workshop, March 2010

Occupational Health and Safety - Program 62

Long-Range Research Initiative Global Research Strategy

LONG-RANGE RESEARCH INITIATIVE Global Research Strategy ADVANCING CHEMICAL SAFETY ASSESSMENT FOR THE 21ST CENTURY

Transcription:

Human Biomonitoring in EU- Funded Research: an update Dr Tuomo Karjalainen Research Programme Officer Research and Innovation Directorate-General Climate Change and Natural Hazards Unit Tuomo.Karjalainen@ec.europa.eu Expert meeting of EU authorities on the use of human biomonitoring as policy tool in chemical risk assessment Brussels, February 2, 2012 15/02/2012

HBM-related issues in the European Commission: history and actors involved

Funding of research Policy making Main DGs and agencies of the Commission addressing E&H health issues Environment Directorate Health Directorate Biotechnologies, Agriculture, Food Directorate Industrial Technologies Directorate Policies on chemicals, EDC strategy, air pollution, noise, water pollution, biodiversity, LIFE+ programme, 6th Environment Action Programme. Public health issues (EMF, indoor air, ETS), EU legislation on food contaminants, risk assessment committees (Scientific Committee on Health and Environmental Risks, Scientific Committee on Emerging and Newly Identified Health Risks), Programme of Community Action in the Field of Health 2008-2013 Policies on safety of goods, REACH Occupational health Other actors Reporting, analyses, advice Implementation of REACH Chemical testing, monitoring, policy support, research

Human exposure monitoring and surveillance: what do policies say? HBM? Responsible DG/agency? European Environment and Health Action Plan Yes Stockholm convention on persistent organic pollutants (POPs) EC Directive 98/24/EC (the Chemical Agents Directive ), as supplemented by Directives 2000/39/EC and 2006/15/EC Directive 2009/128/EC establishing a framework for Community action to achieve the sustainable use of pesticides Community strategy for endocrine disrupters Community Strategy for dioxins, furans and polychlorinated biphenyls EU water framework directive Yes Yes No, but No No No EU air quality directive The REACH regulation No No

Stockholm Convention on Persistent Organic Pollutants (POPs) as amended in 2009 ARTICLE 11 Research, development and monitoring 1. The Parties shall, within their capabilities, at the national and international levels, encourage and/or undertake appropriate research, development, monitoring and cooperation pertaining to persistent organic pollutants and, where relevant, to their alternatives and to candidate persistent organic pollutants, including on their: (a) Sources and releases into the environment; (b) Presence, levels and trends in humans and the environment; (c) Environmental transport, fate and transformation; (d) Effects on human health and the environment; (e) Socio-economic and cultural impacts; (f) Release reduction and/or elimination; and (g) Harmonized methodologies for making inventories of generating sources and analytical techniques for the measurement of releases. 2. In undertaking action under paragraph 1, the Parties shall, within their capabilities: (a) Support and further develop, as appropriate, international programmes, networks and organizations aimed at defining, conducting, assessing and financing research, data collection and monitoring, taking into account the need to minimize duplication of effort; (b) Support national and international efforts to strengthen national scientific and technical research capabilities, particularly in developing countries and countries with economies in transition, and to promote access to, and the exchange of, data and analyses; (c) Take into account the concerns and needs, particularly in the field of financial and technical resources, of developing countries and countries with economies in transition and cooperate in improving their capability to participate in the efforts referred to in subparagraphs (a) and (b); (d) Undertake research work geared towards alleviating the effects of persistent organic pollutants on reproductive health; (e) Make the results of their research, development and monitoring activities referred to in this paragraph accessible to the public on a timely and regular basis; and (f) Encourage and/or undertake cooperation with regard to storage and maintenance of information generated from research, development and monitoring.

EC Directive 98/24/EC (the Chemical Agents Directive ) Unless the employer clearly demonstrates by other means of evaluation that, in accordance with paragraph 2, adequate prevention and protection have been achieved, the employer shall carry out on a regular basis, and when any change occurs in the conditions which may affect workers' exposure to chemical agents, such measurements of chemical agents which may present a risk to worker's health at the workplace as are necessary, in particular in relation to the occupational exposure limit values. Health and exposure records shall contain a summary of the results of health surveillance carried out and of any monitoring data representative of the exposure of the individual. Biological monitoring and related requirements may form part of health surveillance.

Directive on the sustainable use of pesticides To enhance the comparability of information, the Commission, in cooperation with the Member States, shall develop by 14 December 2012 a strategic guidance document on monitoring and surveying of impacts of pesticide use on human health and the environment.

www.ehes.info Final conference 6-7 March 2012 Brussels

HBM and research HBM has many potential benefits: provides a potentially rich picture of an individual s past exposures; may identify long-term trends in the population; can identify locations with high body burdens; can evaluate effectiveness of policy decisions etc. Research aspects: improvement of biomarkers (exposure, effect if linked to health data; susceptibility). Investigation of real-life chemical mixtures. HBM can reveal priorities for research. My opinion: Investigations of the presence and significance of health effects after a given level of exposure should be the main purpose of research funding related to HBM

DG Research and Innovation: Involvement in HBM 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2020 Parallel activities in MS (German Environmental Survey (GerES), VL ) and in the world (US the National Health and Nutrition Examination Survey (NHANES), Canada, Japan)

Societal challenge Health, Demographic Change and Wellbeing, Specific activity 1.1. Understanding the determinants of health, improving health promotion and disease prevention A better understanding of the determinants of health is required in order to provide evidence for effective health promotion and disease prevention, and will also allow the development of comprehensive health and wellbeing indicators in the Union. Environmental, behavioural (including life-style), socio-economic and genetic factors, in their broadest senses will be studied. Approaches will include the long term study of cohorts and their linkage with data derived from "-omics" research, and other methods. In particular, a better understanding of the environment as a determinant of health will require integrated molecular biological, epidemiological and toxicological approaches to investigate health-environment relationships, including studies of modes of action of chemicals, combined exposures to pollution and other environmental and climate related stressors, integrated toxicological testing as well as alternatives to animal testing. Innovative approaches to exposure assessment are needed using new-generation biomarkers based on 'omics' and epigenetics, human biomonitoring, personal exposure assessments and modelling to understand combined, cumulative and emerging exposures, integrating socio-economic and behavioural factors. Improved links with environmental data using advanced information systems will be supported. In this way, existing and planned policies and programmes can be assessed and policy support provided. Similarly, improved behavioural interventions, prevention and education programmes can be developed including those pertaining to health literacy in nutrition, vaccination and other primary care interventions.

Unresolved issues with HBM Surveillance is observational in nature and is at the interface between research and policy : who should fund it? Funding in Horizon 2020? Link to EHES? New EHAP? Any new policy initiatives to propose HBM?

Additional information available http://ec.europa.eu/research/environment/index_en.cfm